| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Director
2 companies
Scott Kathleen D. is a Director at DRMA with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 4 sells.
Estimated insider holdings value: $122K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 21, 2025 | SPRY Ars Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 12,500 | $15.00 | $187,500.00 | -55.5% | -52.3% | - | |
| May 20, 2025 | SPRY Ars Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 50,000 | $14.10 | $705,165.00 | -87.1% | -2.1% | - | |
| Oct 16, 2024 | SPRY Ars Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 12,500 | $16.00 | $200,000.00 | -71.6% | -31.2% | -38.8% | |
| Aug 20, 2024 | SPRY Ars Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 12,500 | $16.00 | $200,000.00 | -48.6% | -7.5% | -1.9% | |
| Nov 29, 2022 | SPRY Ars Pharmaceuticals, Inc. | Chief Financial Officer | Buy | 8,250 | $6.24 | $51,506.40 | New | +40.7% | -20.5% |